Recent new drugs, such as bevacizumab (Bev), also result in a remarkable response. However, the safety of major lung resection after the use of Bev remains controversial. Is it really dangerous to perform major lung resection after the use of Bev for a lung tumor? In this report, we describe two patients who underwent surgery safely without fragile pathological findings of the vessels.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843098 | PMC |
http://dx.doi.org/10.1016/j.amsu.2016.01.081 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!